Skip to content

Gomdori Medical

Evidence-Based Medical Education by gomdori, MD

MENU
  • Home
  • Gastroenterology
  • Procedures
  • Critical Care
  • More Specialties
    • Cardiovascular Medicine
    • Respiratory Medicine
    • Nephrology & Renal Care
    • Hematology
    • Oncology
    • Endocrinology
    • Allergy & Immunology
    • Infectious Diseases
    • Rheumatology
  • Tools
  • About gomdori Medical
  • Conference News
  • Clinical Library
Home » Vertebral Artery Dissection: Diagnosis, CADISS-Guided Antithrombotic Therapy, and Endovascular Indications

Vertebral Artery Dissection: Diagnosis, CADISS-Guided Antithrombotic Therapy, and Endovascular Indications

Posted on August 18, 2026October 17, 2026 by Gomdori
Home › Neurology › Vertebral Artery Dissection
Neurology · Cerebrovascular Emergency

Vertebral Artery Dissection: Diagnosis, CADISS-Guided Antithrombotic Therapy, and Endovascular Indications

A practical playbook for one of the most missed causes of posterior-circulation stroke in young and middle-aged adults — focusing on neck-pain triggers, MRA/CTA imaging, the CADISS-guided antiplatelet vs anticoagulation choice, and when to escalate to endovascular intervention.

📅 Updated April 2026👤 gomdori, MD⏱ 17 min read
Referenced Clinical Guidelines
AAN
American Academy of Neurology
Evidence-based guidelines in neurology
NICE
National Institute for Health and Care Excellence
UK evidence-based clinical guidance

In this article

  1. Anatomy & pathophysiology
    • V1–V4 segments
    • Mechanism of dissection
  2. Risk factors & clinical presentation
    • Triggers
    • Wallenberg + locked-in
  3. Imaging & diagnosis
    • CTA, MRA, MRI fat-sat
  4. Antithrombotic therapy
    • CADISS evidence
  5. Special situations & endovascular
    • SAH, expanding aneurysm, recurrence
  6. Pearls, pitfalls & FAQ
Executive Summary

Vertebral artery dissection (VAD) is the cause of approximately 20% of strokes in adults under 45 and is together with carotid dissection grouped under "cervical artery dissection" (CAD). The classic presentation is posterior neck or occipital pain followed by posterior-circulation ischemic symptoms — most commonly the lateral medullary (Wallenberg) syndrome — though the spectrum runs from isolated headache to brainstem stroke and rarely subarachnoid hemorrhage when the dissection extends intracranially. Diagnosis rests on CTA or MRA of the neck, looking for the long tapered ("string sign"), pseudoaneurysm, intramural hematoma (T1 fat-saturated MRI: hyperintense crescent), or occlusion. The landmark CADISS trial (2015 + 2019 follow-up) demonstrated that antiplatelet therapy is non-inferior to anticoagulation for stroke prevention, simplifying management for most patients to aspirin or clopidogrel for 3–6 months, with anticoagulation reserved for specific scenarios. Endovascular stenting and embolization are reserved for expanding pseudoaneurysm, recurrent ischemia despite optimal medical therapy, or extension into the basilar circulation. Most patients recover well, but recognizing the diagnosis early — especially in young patients with non-specific neck pain after minor trauma or chiropractic manipulation — is the difference between a brief admission and a devastating stroke.

~3/100k
Annual incidence (CAD)
~20%
Stroke in adults <45 yr
~40 yr
Mean age at presentation
~75%
Recanalize at 6 months

1 · Anatomy & Pathophysiology

The vertebral arteries arise from the subclavian arteries and traverse four anatomic segments: V1 (origin to C6 transverse foramen), V2 (within the transverse foramina C6-C2), V3 (extracranial loop from C2 to dura, including the mobile suboccipital segment), and V4 (intracranial, from dural penetration to basilar artery confluence). The V3 segment is the most mobile and the most commonly involved in dissection because head rotation and extension produce shear stress at this exposed location. The V1 origin and V2 transverse foramen segments are protected by surrounding bony structures and less commonly affected. V4 dissections carry the additional risk of subarachnoid hemorrhage from intradural rupture, distinct from the ischemic stroke risk that dominates extracranial dissections.

Dissection begins with an intimal tear allowing blood to enter the vessel wall, creating a false lumen and intramural hematoma that may either narrow the true lumen (producing thromboembolic stroke through stasis and thrombus formation) or expand outward as a pseudoaneurysm (carrying risks of growth, rupture, or thromboembolism from intra-pseudoaneurysm thrombus). The Marfan, Ehlers-Danlos type IV (vascular), fibromuscular dysplasia, and other connective tissue substrates increase baseline dissection susceptibility, but most dissections occur in patients without identifiable connective tissue disease. The mechanism is often trivial — chiropractic manipulation, yoga positions, vigorous coughing or sneezing, sports activities, or even abrupt head turning — rather than major trauma, which is one reason the diagnosis is frequently delayed.

Vertebral artery anatomy — four segments

SegmentCourseDissection notes
V1 (pre-foraminal)Subclavian origin → C6 transverse foramen entryLess mobile; rare dissection site
V2 (foraminal)Through C6–C2 transverse foraminaLess commonly dissected (bony protection)
V3 (atlantic / extradural)C2 → exits transverse foramen → loops behind C1 lateral mass → enters dura at foramen magnumMost common dissection site due to high mobility during head rotation
V4 (intradural / intracranial)Pierces dura → joins contralateral VA at pontomedullary junction → forms basilar arteryIntracranial dissection → SAH risk; thinner adventitia

The "PICA" relationship

The posterior inferior cerebellar artery (PICA) typically arises from the V4 segment and supplies the lateral medulla and inferior cerebellum. Occlusion at this level produces the classic Wallenberg syndrome (lateral medullary syndrome). Many VADs cause infarction here.

Mechanism of dissection

VAD occurs when a tear in the intima allows blood to enter the vessel wall, creating an intramural hematoma that can:

  • Subintimal hematoma → narrows the true lumen → thromboembolism from luminal thrombus is the dominant stroke mechanism (~80%) — emboli to PICA, SCA, basilar tip
  • Subadventitial hematoma → outpouching → pseudoaneurysm; can occlude or generate emboli
  • Transmural tear (intracranial V4 only, where adventitia is thin) → subarachnoid hemorrhage (~10% of intracranial dissections)
Key teaching pointThe majority of VAD-related strokes are artery-to-artery emboli, not direct hypoperfusion. This pathophysiology is why antithrombotic therapy works and why imaging looks for distal clots, not just luminal narrowing.

2 · Risk Factors & Clinical Presentation

Triggers and predisposing conditions

CategoryExamplesPearl
Trivial trauma / mechanicalCervical manipulation/chiropractic, yoga (extreme rotation), sports (martial arts, weight lifting), roller coaster, head/neck whiplash, prolonged dental workOften only minor; pursued aggressively in history when index of suspicion present
Major traumaMVC, fallScreen with CTA per Denver/Memphis criteria
Connective tissue diseaseEhlers-Danlos type IV (vascular), Marfan, fibromuscular dysplasia (FMD), osteogenesis imperfectaFMD found in ~15% of CAD; "string of beads" on imaging
Hereditary / familialα1-antitrypsin deficiency; familial CAD without identified geneFamily history of dissection or aortopathy
Recent infectionURTI, vigorous coughing, vomiting"Dissection seasons" mirror respiratory virus seasons
HypertensionEspecially poorly controlledIndependent risk factor for both onset and recurrence
Migraine with aura3-fold increased riskPossible shared vascular susceptibility
Hyperhomocysteinemia, hormonal contraceptivesModest associationsTreat reversible factors

Clinical presentation — the typical triad

  1. Posterior neck or occipital pain (sometimes severe headache) — present in 70–80%; often the first and only initial symptom for hours to weeks before stroke
  2. Posterior-circulation ischemic symptoms — vertigo, ataxia, nausea/vomiting, diplopia, dysarthria, dysphagia, focal weakness
  3. Defined posterior-circulation stroke syndrome — most commonly Wallenberg (lateral medullary) syndrome
The "headache that becomes a stroke"The interval between dissection-related neck pain and stroke is typically days to 2 weeks. This is the diagnostic window — imaging during the "warning headache" can save the brain. Any young patient with sudden, severe, atypical posterior neck or occipital pain, especially after recent trauma or chiropractic manipulation, deserves urgent CTA/MRA.

Wallenberg (lateral medullary) syndrome — classic presentation

Structure affectedSymptom
Vestibular nucleiVertigo, nystagmus, nausea, vomiting
Spinothalamic tractContralateral loss of pain & temperature in body
Trigeminal nucleus & tractIpsilateral loss of pain & temperature in face
Inferior cerebellar peduncleIpsilateral cerebellar ataxia
Nucleus ambiguus (CN IX, X)Ipsilateral dysphagia, dysphonia, ↓ gag reflex
Descending sympathetic fibersIpsilateral Horner syndrome (ptosis, miosis, anhidrosis)
HiccupsSometimes prominent and persistent

Other posterior-circulation presentations

  • Cerebellar infarction (PICA, AICA, SCA territories) — vertigo, ataxia, headache
  • "Top-of-the-basilar" syndrome — bilateral thalamic/midbrain infarcts; visual symptoms, behavioral changes, decreased consciousness
  • Locked-in syndrome (basilar occlusion) — quadriparesis with preserved consciousness, vertical eye movements only
  • Pure vertigo / dizziness — VAD is an under-recognized "central" cause; suspect when accompanied by neck pain or HINTS-positive findings
  • Thunderclap headache + meningismus → consider intracranial dissection with SAH

HINTS-plus exam (for vertigo presentations)

Head-impulse, Nystagmus, Test-of-Skew + new hearing loss. A "central" pattern (normal head impulse, direction-changing nystagmus, vertical/skew deviation, or new hearing loss) suggests posterior-circulation stroke and should trigger MRI/MRA. HINTS outperforms early MRI within the first 24–48 h for vertebrobasilar stroke detection in expert hands.

VAD Subtypes Comparison table: VAD Subtypes Spontaneous Traumatic Extracranial (V1-V3) Intracranial (V4) Bilateral / recurrent Description 40% have minor trauma trigger; FMD, EDS, Marfan associated MVC, sports, chiropractic manipulation; younger patients Most common (90%); mostly antithrombotic only Higher SAH risk if pseudoaneurysm; antithrombotic with caution Connective tissue disease screen (FMD, EDS); high recurrence
VAD Categories
Vertebral artery dissection diagnostic and treatment pathway Pathway starting from clinical suspicion, branching to CTA/MRA imaging, then treatment based on presence of stroke and SAH features and choice between antiplatelet and anticoagulation per CADISS. Suspect VAD: neck pain + posterior circulation symptoms or focal neuro deficit CTA neck (1st line) or MRA + T1 fat-sat MRI String sign, intramural hematoma, pseudoaneurysm Extracranial only + no SAH (majority) Intracranial + SAH (rare but emergency) Eligible for IV tPA? (within 4.5 h, no SAH) CADISS-guided Antiplatelet • ASA 81–325 mg daily • OR clopidogrel 75 mg × 3–6 months Avoid antithrombotics! • Secure aneurysm endovascularly (coiling/ flow-diverter/sacrifice) • Nimodipine for vasospasm IV alteplase OK • Extracranial dissection is NOT a contraindication • Mechanical thrombectomy for LVO basilar

Figure 1. Vertebral artery dissection diagnostic and treatment pathway.

3 · Imaging & Diagnosis

Imaging modality choice

ModalitySensitivity / specificityPearls
CT angiography (CTA) neck + intracranial~95% / ~95%First-line in ED — fast, widely available; sees luminal narrowing, pseudoaneurysm, occlusion
MR angiography (MRA) + T1 fat-saturated MRI~95% / ~95%Gold standard for intramural hematoma — appears as a hyperintense crescent in the vessel wall on axial T1 fat-sat (best 1–8 weeks after dissection)
Doppler ultrasoundLower (operator-dependent)Useful screening if other modalities unavailable; cannot evaluate intracranial segment
Digital subtraction angiography (DSA)Gold-standard but invasiveReserved for ambiguous cases or planned endovascular intervention

Classic imaging findings

  • Long, tapered narrowing ("string sign") — most common
  • Intramural hematoma (T1 fat-sat MRI hyperintense crescent) — most specific
  • Pseudoaneurysm — outpouching, especially V3 segment after horizontal portion at C1–C2
  • Intimal flap — true and false lumens (less common in VAD than carotid)
  • Complete occlusion with abrupt cutoff
  • Distal embolus — visible thrombus in PICA, SCA, basilar, or PCA territory
Image both arteries and the brainBrain MRI with DWI is essential to detect ischemic infarcts. The pattern (PICA territory, multiple emboli, basilar tip) often confirms the dissection mechanism even when the dissection itself is subtle. Always image the carotid arteries simultaneously — bilateral or multi-vessel CAD occurs in ~15%.

When to suspect SAH

Sudden severe ("thunderclap") headache, neck stiffness, photophobia, or decreased consciousness in a patient with VAD warrants urgent non-contrast head CT. If negative within 6 hours and clinical suspicion remains high, perform a lumbar puncture (xanthochromia). Intracranial V4 dissections carry a ~10% SAH risk; SAH from a dissecting pseudoaneurysm has a high re-bleed rate without securing.

Differential diagnosis for vertigo with neck pain

  • Benign paroxysmal positional vertigo (BPPV) — Dix-Hallpike positive, no neck pain
  • Vestibular neuritis — sustained vertigo, normal neuroimaging
  • Migraine with brainstem aura
  • Lateral medullary infarct from atherosclerotic disease (older patient, vascular risk factors)
  • Posterior fossa tumor
  • Cervicogenic vertigo, atlantoaxial instability
VAD Stepwise Surgical stepper: VAD Stepwise VAD Stepwise 1 Diagnosis CTA or MRA (gold standard); look for intimal flap, intramural hematoma, taper, pseudoaneurysm; conve 2 Acute stroke Standard ischemic stroke care: tPA eligible if no contraindication; thrombectomy if LVO 3 Antithrombotic — CADISS Antiplatelet (aspirin 81-325mg) OR anticoagulation (warfarin/DOAC) — equivalent in CADISS; aspirin m 4 Anticoagulation considerations Anticoagulation preferred for: pseudoaneurysm with thrombus, recurrent ischemia despite ASA, occlude 5 Endovascular Stent for: failed medical management, expanding pseudoaneurysm, persistent SAH risk; coiling for rup 6 Follow-up Repeat MRA at 3-6 months; healing in 70-90%; continue ASA 12 months; activity restriction (no chirop
VAD Algorithm

4 · Antithrombotic Therapy — CADISS-Guided Choice

The CADISS trial — the foundational evidence

The Cervical Artery Dissection in Stroke Study (CADISS) randomized 250 patients (118 vertebral, 132 carotid) within 7 days of CAD to antiplatelet (aspirin alone, clopidogrel alone, dipyridamole, or combinations) vs anticoagulation (heparin → warfarin INR 2–3) for 3 months.

EndpointAntiplateletAnticoagulationResult
Stroke or death at 3 months (primary)3 of 126 (2.4%)1 of 124 (0.8%)OR 0.34 (NS) — non-inferior
Stroke or death at 1 year3.5%2.5%NS
Major bleeding0%1 (intracranial)Slight excess on AC
ConclusionAntiplatelet therapy is non-inferior to anticoagulation for stroke prevention in extracranial CAD; antiplatelet is preferred due to safety and convenience

Recommended antithrombotic regimens

Default (extracranial dissection without high-risk features)
  • Aspirin 81–325 mg PO daily (most common choice) A
  • OR clopidogrel 75 mg PO daily if aspirin-intolerant
  • OR DAPT (aspirin + clopidogrel) for 21–90 days if minor stroke/TIA per POINT/CHANCE-2 protocols, then single antiplatelet
  • Duration: 3–6 months, then re-image
  • Continue indefinitely if vessel still narrowed/occluded or persistent ischemia risk

When to choose anticoagulation

Despite CADISS, anticoagulation remains reasonable in selected scenarios where antiplatelet therapy may be insufficient:

  • Free-floating intraluminal thrombus on imaging
  • Recurrent stroke or TIA on antiplatelet therapy (true antiplatelet failure)
  • Pseudo-occlusion with persistent embolic events
  • Severe stenosis with high-risk anatomy (cardiology/neurology consultation reasonable)
DrugDoseNotes
Heparin80 U/kg IV bolus → 18 U/kg/hr (target aPTT 60–80 s)Acute setting; bridging
WarfarinTarget INR 2–3Traditional choice; predictable monitoring
DOAC (apixaban / rivaroxaban)Apixaban 5 mg PO BID or rivaroxaban 20 mg dailyIncreasing use; no head-to-head trials in CAD; reasonable in non-pregnant patients without renal failure

Acute reperfusion in VAD-related stroke

  • IV alteplase (0.9 mg/kg, max 90 mg, 10% bolus + 90% over 60 min) is NOT contraindicated by extracranial dissection within the standard 4.5 h window
  • Mechanical thrombectomy for large-vessel basilar occlusion — outcomes comparable to non-dissection LVO; consider stenting only if revascularization fails
  • Avoid IV thrombolysis in confirmed intradural V4 dissection with SAH (rare scenario)

Adjunct measures

  • BP control — moderate; avoid both hypertension (aneurysm risk) and hypotension (hypoperfusion)
  • Activity restriction — avoid heavy lifting, vigorous neck rotation, sports for 4–6 weeks (anecdotal but standard)
  • Avoid chiropractic manipulation permanently in dissection patients
  • Statin — for any patient with stroke/TIA per standard secondary-prevention guidelines
  • Smoking cessation, hypertension treatment, contraceptive review

Follow-up imaging

Repeat MRA or CTA at 3 and 6 months. Most dissections recanalize substantially by 6 months. Antithrombotic therapy can usually be discontinued or stepped down to single antiplatelet at this point; persistent occlusion or pseudoaneurysm may warrant indefinite antiplatelet.

5 · Special Situations & Endovascular Therapy

Subarachnoid hemorrhage from intracranial VAD

Avoid antithromboticsSAH from a dissecting pseudoaneurysm has a re-bleed rate of 30–70% within the first month if left unsecured. Antiplatelet/anticoagulation is contraindicated. The aneurysm must be secured promptly.
ApproachIndicationNotes
Endovascular coilingSaccular pseudoaneurysm with preservation of parent vessel possibleFirst-line; reasonable PICA preservation rates
Flow-diverter stentFusiform/dissecting aneurysm where parent vessel must be preserved (eg dominant VA, contralateral hypoplasia)Pipeline-class stents; need DAPT (challenging post-SAH)
Vessel sacrifice (parent artery occlusion)Non-dominant V4, contralateral VA patent, no PICA arising from segmentDefinitive; must verify collateral via balloon test occlusion
Surgical clipping / wrappingFailure of endovascular optionsRare; high morbidity in posterior circulation

Add nimodipine 60 mg PO/NG q4h × 21 days for vasospasm prophylaxis after SAH (start within 96 h of bleed; reduce to 30 mg q2h if hypotensive).

Endovascular stenting for non-SAH dissection

Endovascular stenting of the extracranial vertebral artery has limited indications and no proven survival benefit:

  • Recurrent stroke despite optimal medical therapy
  • Expanding pseudoaneurysm (>1 cm growth on follow-up imaging)
  • Symptomatic hemodynamic compromise (rare; usually with bilateral disease or hypoplastic contralateral VA)

Recurrent dissection

  • Risk highest in first month (~2%); declines to ~1%/yr thereafter
  • Highest risk in connective tissue disease (Ehlers-Danlos vascular, FMD), young age, family history
  • If recurrence on antiplatelet → switch to anticoagulation; consider genetic workup
  • Counsel against high-risk activities (chiropractic, contact sports, extreme yoga, roller coasters)

Pregnancy considerations

  • Pregnancy and postpartum period (especially first 6 weeks) increase CAD risk
  • Aspirin is safe throughout pregnancy
  • If anticoagulation needed: heparin/LMWH during pregnancy (warfarin teratogenic in 1st trimester)
  • Subsequent pregnancies after CAD generally safe but warrant high-risk obstetrics co-management

Connective tissue disease workup — when to refer to genetics

  • Multi-vessel dissection
  • Recurrent dissection
  • Family history of dissection or aortic aneurysm
  • Stigmata of EDS (hyperextensible skin, joint hypermobility, easy bruising) or Marfan (tall, arachnodactyly, lens dislocation, aortic root dilation)
  • Imaging signs of FMD (string of beads in renal/cerebral arteries) → renal artery imaging, vascular surgery consult
When to refer to a comprehensive stroke center / neurointervention
  • Intracranial dissection (V4 segment)
  • SAH from suspected dissecting aneurysm
  • Recurrent ischemia despite optimal medical therapy
  • Large basilar territory infarct (consider thrombectomy)
  • Pseudoaneurysm >1 cm or growing
  • Bilateral CAD (vertebral + carotid)
  • Pregnant patients with CAD

6 · Pearls, Pitfalls & FAQ

Pearls

  • Posterior neck pain after minor neck rotation — chiropractic, vigorous yoga, head turn while parking — in a young/middle-aged adult is VAD until proven otherwise. CTA neck within 24 hours.
  • The pain–stroke interval averages days to 2 weeks. Imaging during the warning headache phase prevents the stroke.
  • CADISS established antiplatelet equivalence for extracranial dissection. Aspirin 81 mg daily for 3–6 months suffices for the majority. Avoid the reflex to anticoagulate everyone.
  • Wallenberg syndrome on exam = lateral medullary infarct = PICA territory = check for VAD. The exam (ipsilateral Horner + facial sensory loss + contralateral body sensory loss + cerebellar findings) is one of the most specific in neurology.
  • Image both vertebral and carotid arteries — bilateral or multi-vessel dissection occurs in ~15%, often missed if you only image one side.

Pitfalls

  • Dismissing isolated neck pain as muscular in a young patient with no obvious red flags — this is the most common diagnostic miss.
  • Reflexively anticoagulating all dissections — CADISS shows aspirin works equally well with less bleeding risk; anticoagulation should be reserved for specific failures or free thrombus.
  • Giving antithrombotics in intracranial dissection with SAH — life-threatening; image the head with non-contrast CT before treating.
  • Withholding IV alteplase in eligible patients within 4.5 h because of an extracranial dissection — extracranial CAD is NOT a contraindication to thrombolysis.
  • Forgetting to image follow-up at 3 and 6 months — recanalization rate guides duration of antithrombotic therapy.
  • Not screening for connective tissue disease in young/recurrent CAD — missing FMD, EDS, or Marfan can lead to subsequent aortic catastrophe.

Frequently Asked Questions

Should I anticoagulate or use antiplatelet for vertebral artery dissection?
For most extracranial vertebral artery dissections, antiplatelet therapy with aspirin 81–325 mg daily (or clopidogrel 75 mg daily if aspirin-intolerant) is the preferred first-line therapy. The CADISS trial (2015) showed antiplatelet therapy was non-inferior to anticoagulation (warfarin INR 2–3) for stroke prevention at 3 months and 1 year, with comparable bleeding risk. Anticoagulation remains a reasonable option in specific scenarios: a free-floating intraluminal thrombus on imaging, recurrent stroke or TIA despite antiplatelet therapy, or pseudo-occlusion with persistent embolic events. Direct oral anticoagulants are increasingly used despite limited trial data. Treatment duration is 3–6 months, then re-imaging guides whether to continue, step down to single antiplatelet, or stop entirely.
What is the role of chiropractic neck manipulation in causing vertebral artery dissection?
Cervical manipulation by chiropractors or other manual therapists is a documented but uncommon trigger for vertebral artery dissection. The relationship is complicated by reverse causation — patients may seek manipulation for the very same neck pain that signals an evolving dissection. Case-control studies suggest a 3–6-fold increased risk of VAD in the days following manipulation, particularly with rotational thrust techniques. The absolute risk per manipulation remains very low (estimated 1 in 100,000–1,000,000), but in patients who have already had a dissection, future manipulation is contraindicated, and patients with risk factors (connective tissue disease, FMD, prior dissection) should avoid these procedures.
Is intravenous thrombolysis safe in acute stroke from vertebral artery dissection?
Yes — extracranial vertebral artery dissection is NOT a contraindication to intravenous alteplase 0.9 mg/kg within the standard 4.5-hour window for acute ischemic stroke. Multiple registries and meta-analyses have shown that hemorrhagic transformation rates and 90-day outcomes are comparable to non-dissection stroke. The exception is intradural (intracranial V4) dissection with concurrent subarachnoid hemorrhage — IV alteplase is contraindicated here, and the priority is securing the dissecting aneurysm. For large basilar artery occlusion from a dissection, mechanical thrombectomy is appropriate and has comparable success rates to non-dissection LVO.
When should I image follow-up for vertebral artery dissection, and what should clinicians look for?
Repeat non-invasive imaging (CTA or MRA) at 3 months and again at 6 months. The goals are: (1) document recanalization (occurs in 60–80% by 6 months); (2) identify residual stenosis or pseudoaneurysm; (3) decide whether to continue, step down, or stop antithrombotic therapy. If the vessel has fully recanalized and no pseudoaneurysm remains, antithrombotics can typically be discontinued. If a pseudoaneurysm persists, consider continuing single antiplatelet long-term. If pseudoaneurysm is enlarging by >1 cm or new symptoms develop, refer for endovascular evaluation. T1 fat-saturated MRI sequences are preferred at follow-up to confirm resolution of intramural hematoma.
When should clinicians order genetic testing for connective tissue disease in vertebral artery dissection?
Refer for genetic evaluation when the patient has any of: multi-vessel dissection (bilateral CAD or carotid + vertebral), recurrent dissection, family history of dissection or aortic aneurysm, age <30 years, or physical signs suggesting Ehlers-Danlos vascular type (translucent skin, easy bruising, prior arterial complications) or Marfan syndrome (tall stature, arachnodactyly, ectopia lentis, aortic root dilation). Testing typically includes COL3A1 (vascular EDS), FBN1 (Marfan), TGFBR1/2 (Loeys-Dietz), and a panel of arteriopathy genes. Imaging features of fibromuscular dysplasia ("string of beads") in the renal or other arteries warrant vascular surgery referral and renal imaging — not all FMD has a single gene cause, but it modifies surveillance.

Practice Insights — Synthesized Patterns for Vertebral Artery Dissection Care

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)Across published practice patterns, clinicians have learned that this diagnosis is missed in the ED far more often than it is over-called. The young patient with neck pain and dizziness who gets reassurance and ibuprofen — then returns 48 hours later with a posterior-circulation stroke — is the case that should not happen but still does. Below is how experienced clinicians actually approach the diagnostic workup.

Neck Pain + Neurologic Symptom = Image

In practice, any patient with neck pain plus ANY neurologic symptom (vertigo, dysarthria, ataxia, visual symptoms, Horner's, hemiparesis, diplopia, dysphagia, even transient) gets immediate CTA neck or MRA. The neck pain alone is non-specific; the neurologic symptom alone might be benign; the combination of even mild pain plus subtle neurology is the dissection profile. The reflex "neck pain → muscle strain → ibuprofen and discharge" misses this entirely. clinicians have inherited multiple "missed VAD" cases discharged from prior ED visits with exactly this pattern.

Trivial Mechanism Counts

The reflex "no major trauma, can't be dissection" is wrong. In experienced hands, VAD frequently follows: chiropractic manipulation, yoga inversions, vigorous coughing or sneezing, hair-washing at salons (the "beauty parlor syndrome"), playing certain sports, and even routine head-turning in susceptible individuals. The mechanism may be trivial in retrospect; the dissection is real. Seasoned clinicians ask specifically about recent neck manipulation, novel exercise routines, sports activities, severe coughing illness — not just "any trauma."

CADISS — Antiplatelet vs Anticoagulation Equivalent

The CADISS trial settled the long-running antiplatelet-vs-anticoagulation debate: both are equivalent for stroke prevention in cervical artery dissection with low recurrence rates (~2%). In practice, the default is antiplatelet therapy (aspirin 81 mg daily or clopidogrel 75 mg daily) for 3-6 months — easier to manage, less bleeding risk, no INR monitoring. Anticoagulation (warfarin or DOAC) reserved for: documented thromboembolic stroke with high-risk imaging features (free-floating thrombus, occlusion with residual flow), or patient preference. The historical "always anticoagulate" approach is no longer supported.

Endovascular Therapy — Rare, Selected

Endovascular intervention (stenting, coiling of pseudoaneurysm) is rare in VAD. In practice, indications include: completed stroke with persistent severe stenosis and recurrent ischemic symptoms despite optimal medical therapy, expanding pseudoaneurysm with mass effect or growing size on serial imaging, or hemodynamic stroke from severely diminished posterior circulation flow. The vast majority of VAD patients heal completely with medical management — imaging at 3-6 months typically shows resolution. Reflex endovascular intervention exposes patients to procedural risk for marginal benefit.

Illustrative Scenario — A Case That Defined The Imaging Threshold

(Composite teaching scenario assembled from published patterns; not an individual patient.)

A man in his late 30s presented to ED with 24 hours of severe occipital headache and neck pain, mild dysarthria, and transient blurred vision. He had received chiropractic neck manipulation 2 days prior for chronic neck pain. The initial ED diagnosis was "musculoskeletal neck strain" — he was given ibuprofen and discharged. He returned 36 hours later with lateral medullary syndrome (Wallenberg) — ipsilateral facial sensory loss, contralateral body sensory loss, ataxia, vertigo. CTA confirmed bilateral V3 vertebral artery dissection with PICA territory infarction. He recovered substantially over 6 months but had persistent right-sided ataxia. Retrospective review showed his initial ED visit had all the classic VAD warning features that should have triggered immediate imaging.

The takeaway: chiropractic manipulation + new posterior circulation symptoms = VAD until imaging proves otherwise. The initial ED visit had the diagnosis in the history; missing it cost 36 hours and a completed stroke with permanent deficit. The treating clinicians now teach this pattern in every grand rounds presentation because it is the highest-yield clinical recognition skill in stroke.

Practice Pattern Refinements Beyond the Standard Guideline

  1. CTA neck for any neck pain + neuro symptom — no exceptions. Standard ED order set when both are present: CTA carotid + vertebral arteries. The radiation/contrast cost is justified by the catastrophic miss rate of clinical assessment alone. Specifically ask about chiropractic, yoga, severe cough, sports — these elicit the trivial-mechanism history that musculoskeletal label hides.
  2. MRI brain + MRA neck if CTA equivocal. MRA visualizes mural hematoma directly (T1 fat-saturated) and may catch dissections that CTA misses, particularly subtle V3 lesions or chronic dissections. In ambiguous CTA cases or where contrast is contraindicated, MRA is the next step — not "watchful waiting."
  3. Antiplatelet for 3-6 months, then imaging-driven decision. ASA 81 mg or clopidogrel 75 mg daily for 3-6 months. Repeat CTA/MRA at 3 months to assess healing. If complete resolution → discontinue antiplatelet. If persistent stenosis or pseudoaneurysm → continue antiplatelet indefinitely. The "stay on aspirin forever" reflex misses that healing dissections do not need ongoing therapy.
  4. Document avoidance counseling — chiropractic, contact sports. Discharge instructions explicitly list avoidance of high-velocity neck manipulation, contact sports for 3-6 months, and other dissection-trigger activities. Patient education prevents iatrogenic recurrence. Many patients will return to chiropractic without specific counseling not to.
Vertebral Artery Dissection Framework Four-panel matrix: imaging trigger thresholds, trivial mechanism awareness, CADISS-guided antiplatelet, endovascular indications. VAD Framework Panel 1 — Neck Pain + Neuro = Image Neck pain + ANY of: Vertigo, dysarthria, ataxia, visual sx, Horner's → Immediate CTA neck Or MRA neck if contrast contraindicated "Muscle strain → ibuprofen → discharge" Most common missed-diagnosis pattern Even transient neuro sx counts Subtle symptom + neck pain = VAD until proven otherwise Panel 2 — Trivial Mechanism Counts Chiropractic neck manipulation Yoga inversions / extreme positions Vigorous cough/sneeze, severe vomiting "Beauty parlor" (hair-wash extension) Contact sports, vigorous head turning "No major trauma" reflex misses real triggers Panel 3 — CADISS Settled the Debate Antiplatelet = Anticoagulation ~2% recurrence rate either approach default: ASA 81 mg or clopidogrel 75 mg Easier, less bleeding, no INR monitoring Anticoag if: free-floating thrombus, occlusion High-risk imaging features or patient preference Duration: 3-6 months, then re-image If resolved → stop. If persistent → continue Panel 4 — Endovascular: Rare, Selected Don't reflex stent — most heal medically 3-6 month imaging shows resolution typically Selected indications: Refractory ischemia despite optimal med Tx Expanding pseudoaneurysm with growth/mass Serial imaging documents progression Avoidance counseling at discharge: No chiropractic, no contact sports × 3-6 mo Explicit instructions prevent iatrogenic recurrence
Related clinical topics
More in Neurology
  • Parkinson Disease: Clinical Diagnosis, Dopaminergic Therapy, and Advanced Therapy Options
  • Bell Palsy: AAN Guideline Diagnosis, Steroid Therapy, Antiviral Adjunct, Eye Care, and Recovery Prognosis
  • Migraine: Diagnosis, Acute Treatment, and Preventive Therapy
  • Multiple Sclerosis: Diagnosis, McDonald Criteria, and Disease-Modifying Therapy
  • Alzheimer Disease: AAN Diagnosis, Biomarker Workup, and Anti-Amyloid Therapy
  • Intracerebral Hemorrhage: Acute Blood Pressure, Anticoagulation Reversal, and Surgical Indications
Also published on this site
  • Congenital Adrenal Hyperplasia (CAH): 21-Hydroxylase Deficiency Diagnosis and Management
Posted in NeurologyTagged antiplatelet versus anticoagulation, CADISS trial, cervical artery dissection, connective tissue disease, dissecting aneurysm, fibromuscular dysplasia, neurointervention, posterior circulation stroke, vertebral artery dissection, Wallenberg syndrome

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

61 free tools

Endoscopy Findings Atlas · Explore endoscopic findings and diagnostic distinctions.

Health & clinical tools

Find personal records, research helpers and clinical references.

  • Personal Records & Visits11 tools
  • Measurements & Conversions3 tools
  • Research & Events11 tools
  • Clinical Scores & Tests16 tools
  • Medication & Treatment References14 tools
  • Screening & Procedures6 tools
Browse all 61 tools →

Clinical references are for qualified professionals. Check each tool’s scope and limitations.

Tools to try
  • AUDIT-C Alcohol Screening & Unit Calculator
  • Acute Pancreatitis Severity Calculator
  • Ascites SAAG & SBP Diagnostic Assistant
Support This Project
Help keep medical education free
Donate via PayPal

Recent Posts

  • PAPA Syndrome: PSTPIP1 Autoinflammatory Disease with Pyogenic Sterile Arthritis Pyoderma Gangrenosum and Cystic Acne
  • X-Linked Hypophosphatemia: PHEX FGF23 Renal Phosphate Wasting Hypophosphatemic Rickets and Burosumab Therapy
  • Rocky Mountain Spotted Fever (RMSF): Petechial Palm-Sole Rash, Empiric Doxycycline, and the Don’t-Wait-for-Confirmation Rule
  • Sideroblastic Anemia: Congenital ALAS2, Acquired MDS-RS, Reversible Toxic Causes, and Pyridoxine Therapy
  • Bartonella Endocarditis: B. henselae and B. quintana, Modified Duke Criteria, and Doxycycline-Gentamicin Therapy

Categories

  • Allergy & Clinical Immunology
  • Cardiovascular Medicine
  • Clinical Nutrition
  • Clinical Pharmacology
  • Critical Care Medicine
  • Dermatology
  • Emergency Medicine
  • Endocrinology & Metabolism
  • Gastroenterology
  • General Surgery
  • Geriatric Medicine
  • Hematology & Blood Disorders
  • Infectious Diseases
  • Medical Genetics
  • Nephrology & Renal Care
  • Neurology
  • Obstetrics & Gynecology
  • Occupational & Environmental Medicine
  • Oncology & Cancer Care
  • Ophthalmology
  • Order Sets
  • Orthopedics & Sports Medicine
  • Otolaryngology
  • Pain Medicine
  • Palliative Care
  • Pediatrics
  • Procedures
  • Psychiatry
  • Radiology
  • Respiratory Medicine
  • Rheumatology
  • Sleep Medicine
  • Urology
  • Vaccines & Preventive Medicine

Medical Disclaimer

This content is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for clinical decision-making. The author assumes no liability for actions taken based on this content.

GM

Gomdori, MD

Gastroenterologist · Medical educator

A practising gastroenterologist in South Korea writing bedside-focused clinical education — guideline-derived, dose-precise, and aimed at the decision in front of you rather than the exam question.

Writes about

Gastroenterology & hepatologyEndoscopyGuideline appraisal

Editorial standard

  • Every figure is traced to a primary source and dated
  • Corrections are made on request — not quietly
  • Unverifiable data is omitted, never estimated
About the author Corrections

gomdori Medical

Evidence-based medical education by a practicing gastroenterologist in South Korea. Free clinical content for physicians, residents, and medical students.

Learn more →

Quick Links

  • Gastroenterology
  • Procedures
  • Critical Care
  • About
  • Medical Disclaimer

Contact

Corrections, topic requests, and feedback are always welcome.

gomdoridoctor@gmail.com

Support via PayPal

© 2026 gomdori Medical. All rights reserved.

Content is for educational purposes only and does not constitute medical advice. Full disclaimer

Built with clinical expertise & programmatic precision.

AboutToolsPrivacy PolicyTerms of UseEditorial PolicyDisclaimerContact
Free tools →

© 2026 Gomdori Medical. Educational content only — not professional advice. Figures are dated at the point of publication and change over time; verify against the original source before acting on them.

AboutToolsPrivacy PolicyTerms of UseDisclaimerContact
Free tools →

© 2026 Gomdori Medical. Educational content only — not professional advice. Figures are dated at the point of publication and change over time; verify against the original source before acting on them.

Copyright © 2026 Gomdori Medical – OnePress theme by FameThemes